HD · NYSE
The supplied consensus is Buy across 31 analysts, with a mean price target of $376; consensus low and high targets are not provided. Other aggregators place average targets in a relatively tight central band of $370.18 to $391.96, including MarketBeat at $371.71, while Public reports $388.57. The disclosed outer targets are much wider: Wolfe Research is most bullish at $497 and Oppenheimer least bullish at $310. Revision direction was modestly negative in the supplied commentary, with Simply Wall St. saying its fair-value target was nudged lower by about $2 to $408.18, although no dated, named weekly analyst revision was identified. The substantive disagreement centers on discount rates, long-term revenue growth and profit-margin assumptions.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Oppenheimer | — | $310 | -11.9% | May 18, 2026 | Open the report this row came from | |
| Wolfe Research | — | $497 | +41.3% | Sep 18, 2025 | Open the report this row came from |